AMNEAL PHARMACEUTICALS, INC. Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests of $83.96 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity
us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests · last filed 2026-08-06
- 2026-06-30: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $83.96M.
- 2026-03-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $85.91M.
- 2025-12-31: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $77.29M.
- 2025-09-30: Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests $67.78M.
| Period end | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests |
|---|---|
| 2026-06-30 | $83.96M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $85.91M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $77.29M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $67.78M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $65.80M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $72.61M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $64.97M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $59.89M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $53.42M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $47.02M 10-Q · filed 2025-08-07 |
| 2023-12-31 | $41.29M 10-K · filed 2026-02-27 |
| 2023-09-30 | $37.14M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $32.11M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $27.53M 10-Q · filed 2024-08-09 |
| 2022-12-31 | $24.95M 10-K · filed 2026-02-27 |
| 2022-09-30 | $22.38M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $17.89M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $16.42M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $16.91M 10-K · filed 2025-02-28 |
| 2021-09-30 | $15.26M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $14.11M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $13.08M 10-Q · filed 2022-08-08 |
| 2020-12-31 | $11.80M 10-K · filed 2024-03-14 |
| 2020-09-30 | $11.93M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $12.38M 10-Q · filed 2021-11-08 |
| 2020-03-31 | $12.56M 10-Q · filed 2021-08-09 |
| 2019-12-31 | $0.00 10-K · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |